Turning Microbial AhR Agonists into Therapeutic Agents via Drug Delivery Systems

Developing therapeutics for inflammatory diseases is challenging due to physiological mucosal barriers, systemic side effects, and the local microbiota. In the search for novel methods to overcome some of these problems, drug delivery systems that improve tissue-targeted drug delivery and modulate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Puccetti, Matteo, Pariano, Marilena, Wojtylo, Paulina, Schoubben, Aurélie, Giovagnoli, Stefano, Ricci, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966334/
https://www.ncbi.nlm.nih.gov/pubmed/36839828
http://dx.doi.org/10.3390/pharmaceutics15020506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966334/
https://www.ncbi.nlm.nih.gov/pubmed/36839828
http://dx.doi.org/10.3390/pharmaceutics15020506

Ejemplares similares